Diabetes & Metabolic Syndrome-Clinical Research & Reviews
Impact Factor Trend (2023–2026)
Clarivate IF trend for Diabetes & Metabolic Syndrome-Clinical Research & Reviews
SCImago Journal Rank citation prestige weighting
98 papers with at least that number of citations each
Aims & Scope
Diabetes and Metabolic Syndrome: Clinical Research and Reviews is the official journal of DiabetesIndia. Diabetes and Metabolic Syndrome: Clinical Research and Reviews aims to reach out to healthcare professionals, diabetes educators and other stakeholders, providing them with a global platform to submit their research on diabetes care. The journal publishes research covering various aspects of diabetes and related diseases like cardiovascular diseases, diabetic neuropathy, weakening eyesight, sexual dysfunction, management of diabetes mellitus, obesity, insulin management and metabolic syndrome, among others. The journal publishes peer-reviewed original articles, reviews, short communication, case reports, letter to the Editor and expert comments. Reviews and mini-reviews are especially welcomed for those areas within endocrinology undergoing rapid changes.
Special Issues
Calls for Papers1 Calls for Papers · Automatically synced from ScienceDirect & publishers
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
ENDOCRINOLOGY & METABOLISM
ENDOCRINOLOGY & METABOLISM
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisDiabetes & Metabolic Syndrome-Clinical Research & Reviews (ISSN: 1871-4021) is a peer-reviewed international scholarly journal in the field of ENDOCRINOLOGY & METABOLISM, published by Elsevier in Netherlands. The periodical holds a Journal Impact Factor (JIF) of 4.40, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.170 (Q1), an H-index of 98.
The journal enforces rigorous peer evaluation with an annual output of approximately 304 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,499 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics